Allergan Aesthetics will present data on its leading aesthetic product portfolio at the 2021 American Academy of Dermatological Surgery Virtual Conference

Irvine, California, November 19, 2021/PRNewswire/ – Allergan Aesthetics (NYSE: ABBV), an AbbVie company, today announced that it will showcase its leading aesthetics at the American Academy of Dermatology The Six Summary Surgery (ASDS) conferences in the treatment and product portfolio will be held almost November 19-21, 2021.
Allergan Aesthetics’ product portfolio is one of the most researched product portfolios in the entire beauty industry. In order to continue this tradition, our innovative scientific methods are committed to bringing new and influential treatments to our global customers and their patients.
“Our scientific-based discoveries continue to help advance the advancement of aesthetic medicine; therefore, we attach great importance to the opportunity to share our published data with the medical community,” said Darin Messina, Senior Vice President of Aesthetics R&D at Allergan. “We are honored that the conference has named two BOTOX® Cosmetic (OnabotulinumtoxinA) abstracts as the’best cosmetic oral abstracts’ and look forward to continuing scientific exchanges at ASDS in the coming years.”
Also sharing on ASDS is that Arisa Ortiz, MD, FAAD, will showcase the products of Allergan Aesthetics SkinMedica® TNS® Advanced+ Serum during one of the industry hot topics conference on Saturday, November 20th from 4:15-5:15 pm Information. SkinMedica®’s TNS® Advanced+ Serum for home use is composed of two chambers, which can work together after mixing to bring significant results to young skin. In a clinical study, after topical use of SkinMedica® TNS® Advanced+ Serum at home, noticeable coarse wrinkles and fine lines appeared within 2 weeks, and improved the appearance of skin discoloration and sagging skin after 8 weeks. In addition, in this study, based on the evaluation of a third-party validated psychometric scale, users felt that they looked 6 years younger in just 12 weeks. 1
Views on the reduction of masseter protrusion after botulinum toxin A treatment – ​​Fabi S. et al.
Canada HARMONY study: Comprehensive facial beauty treatments, including submental fullness, can improve patient-reported results – Bertucci V. et al.
Chin surgery with hyaluronic acid filler VYC-20L achieves high patient satisfaction: a subgroup analysis of the phase 3 study – Downie J. et al.
The recently developed hyaluronic acid filler VYC-12L can improve cheek skin smoothness: 6-month results of a prospective study – Alexiades M. et al.
A prospective, open-label study to evaluate the overall improvement of the jaw line contour using ATX-101 and VYC-20L for sequential treatment-Goodman G. et al.
Botulinum toxin A neutralizing antibody transformation in multiple indication studies recorded from nearly 30,000 patients worldwide: a meta-analysis – Ogilvie P. et al.
Important safety information and approved use SBOTOX® Cosmetic may cause serious side effects and may be life-threatening. If you experience any of the following problems at any time (a few hours to a few weeks) after the injection of BOTOX® Cosmetic, please seek medical help immediately:
The dosage unit of BOTOX® Cosmetic is different and different from any other botulinum toxin product. When using BOTOX® Cosmetic at the recommended dose to treat frown lines, crow’s feet and/or forehead lines, no serious cases of the spread of toxin effects have been confirmed. Within hours to weeks after taking BOTOX® Cosmetic, BOTOX® Cosmetic may cause loss of strength or muscle weakness, vision problems or dizziness. If this happens, please do not drive a car, operate machinery, or engage in other dangerous activities.
Severe and/or immediate allergic reactions have been reported. They include: itching, rash, red itchy wounds, wheezing, asthma symptoms, or dizziness or feeling dizzy. If you experience wheezing or asthma symptoms, or feel dizzy or fainting, seek medical help immediately.
Do not accept BOTOX® Cosmetic if you have the following conditions: Allergic to any ingredient in BOTOX® Cosmetic (please refer to the drug guide for ingredients); Allergic reaction to any other botulinum toxin products, such as Myobloc® (rimabotulinumtoxinB), Dysport® (abobotulinumtoxinA) or Xeomin® (incobotulinumtoxinA); skin infection at the planned injection site.
Tell your doctor about all your muscle or nerve conditions, such as ALS or Lou Gehrig’s disease, myasthenia gravis, or Lambert-Eaton syndrome, because you may increase your risk of serious side effects, including difficulty swallowing and breathing after typical doses of BOTOX Difficult ® cosmetics.
Tell your doctor about all your health conditions, including: planned surgery; had surgery on your face; unable to raise eyebrows; drooping eyelids; any other abnormal facial changes; pregnancy or planned pregnancy (don’t know if BOTOX® Cosmetic Will harm your unborn baby); are breastfeeding or planning to breastfeed (do not know whether BOTOX® Cosmetic will pass into breast milk).
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using BOTOX® Cosmetic with certain other medicines may cause serious side effects. Do not start any new medicines until you tell your doctor that you have received BOTOX® Cosmetic in the past.
If you have received any other botulinum toxin products in the past 4 months, please tell your doctor; have injected botulinum toxin in the past, such as Myobloc®, Dysport® or Xeomin® (tell your doctor that you received Which product is it); recently received antibiotics by injection; taking muscle relaxants; taking allergy or cold medicine; taking sleeping pills; taking aspirin-like products or blood thinners.
Other side effects of BOTOX® Cosmetic include: dry mouth; discomfort or pain at the injection site; tiredness; headache; neck pain; and eye problems: double vision, blurred vision, decreased vision, drooping eyelids and eyebrows, swollen eyelids, and dry eyes.
APPROVED USESBOTOX® Cosmetic is a prescription drug injected into the muscle to temporarily improve the appearance of moderate to severe forehead lines, crow’s feet and frown lines in adults.
Approved use JUVÉDERM® VOLUMA™ XC injectable gel is used for deep injections in the cheek area to correct age-related volume loss, and to enlarge the chin area to improve the contour of the chin in adults over 21 years of age.
JUVÉDERM® VOLLURE™ XC, JUVÉDERM® Ultra Plus XC and JUVÉDERM® Ultra XC injectable gels are used to inject facial tissues to correct moderate to severe facial wrinkles and folds, such as nasolabial folds. JUVÉDERM® VOLLURE™ XC injection gel is suitable for adults over 21 years of age.
JUVÉDERM® VOLBELLA™ XC injectable gel is used for injection into the lips for lip augmentation and correction of perioral wrinkles in adults over 21 years of age.
JUVÉDERM® Ultra XC injectable gel is used for injection into the lips and perioral area for lip augmentation in adults over 21 years of age.
Is there any reason why I should not accept any JUVÉDERM® formulations? If you have a history of multiple severe allergies or severe allergic reactions (allergic reactions), or you are allergic to lidocaine or gram-positive bacterial proteins, do not use these products in these products.
What are the possible side effects? The most commonly reported side effects of JUVÉDERM® injection gel include redness, swelling, pain, tenderness, firmness, lumps/lumps, bruising, discoloration and itching. For JUVÉDERM® VOLBELLA™ XC, the dryness is also reported. For JUVÉDERM® VOLUMA™ XC, most side effects subside within 2 to 4 weeks. For JUVÉDERM® VOLLURE™ XC, JUVÉDERM® Ultra Plus XC and JUVÉDERM® Ultra XC injectable gels, most can be separated in 14 days or less. For JUVÉDERM® VOLBELLA™ XC, most are resolved in 30 days or less. These side effects are consistent with other facial injection procedures.
Most side effects will subside over time. Your doctor may choose to use antibiotics, steroids, or hyaluronidase (an enzyme that breaks down hyaluronic acid) to treat side effects that last more than 30 days.
One of the risks of these products is the inadvertent injection of blood vessels. The possibility of this happening is very small, but if it does happen, the complications may be serious and may be permanent. According to reports, these complications of facial injections may include abnormal vision, blindness, stroke, temporary scabs or permanent skin scars.
Visit or consult your doctor for more information. To report any side effects of JUVÉDERM® products, please contact Allergan at 1-800-433-8871.
The products in the JUVÉDERM® series can only be obtained by licensed doctors or appropriately licensed practitioners.
Approved use and important safety information What is KYBELLA®? KYBELLA® is a prescription drug used in adults to improve the appearance and contour of moderate to heavy fat below the chin (submental fat), also known as “double chin”. KYBELLA® can safely and effectively treat fat outside the submental area or in children under 18 years of age.
Who should not accept KYBELLA®? If you have an infection in the treatment area, do not receive KYBELLA®.
Before receiving KYBELLA®, please tell your healthcare provider about all your health conditions, including: facial, neck or chin received cosmetic treatment; have or have had health problems in or near the neck; swallowing or swallowing difficulties ; Have bleeding problems; are pregnant or planning to become pregnant (don’t know if KYBELLA® will harm your unborn baby); are breastfeeding or planning to breastfeed (don’t know if KYBELLA® will pass into your breast milk).
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. If you take medications that prevent blood clotting (antiplatelet drugs or anticoagulants), especially tell your healthcare provider.
The most common side effects of KYBELLA® include swelling, pain, numbness, redness, and hardening of the treated area. These are not all possible side effects of KYBELLA®. Call your doctor and ask for medical advice about side effects.
See full prescribing information for KYBELLA®. Please refer to the attached complete prescription information, or ask your healthcare provider, or visit
SKINMEDICA® Important Safety Information The SkinMedica® product described here is designed to meet the FDA’s definition of cosmetics, which is an article that is applied to the human body to clean, beautify, enhance attractiveness and change appearance. The SkinMedica® product is not intended to be a pharmaceutical product to diagnose, treat, cure or prevent any disease or condition. This product has not been approved by the FDA, and the statements on these pages have not been evaluated by the FDA.
For more information, please consult your provider or visit To report an adverse reaction, please call Allergan at 1-800-433-8871.
About Allergan Aesthetics Allergan Aesthetics is an AbbVie company that develops, manufactures and sells a series of leading aesthetic brands and products. Their beauty product portfolio includes facial injections, body shaping, plastics, skin care and more. Their goal is to consistently provide global customers with innovation, education, excellent service and a commitment to excellence, all of which have a personal style.
About AbbVie AbbVie’s mission is to discover and provide innovative drugs to solve today’s serious health problems and meet future medical challenges. We strive to have a significant impact on people’s lives in several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, as well as the products and services of its Allergan Aesthetics product portfolio . For more information about AbbVie, please visit our website Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

Post time: Nov-23-2021